The World Bank announced on Tuesday the approval of $ 12 billion for developing countries to purchase and distribute the COVID-19 vaccine, as well as financing the tests and treatment against this disease.
The approval of this fund $ 12 billion from the World Bank Board of Executive Directors “It aims to support the vaccination of up to one billion people,” the World Bank said in a statement.
This financing is part of a larger package of the World Bank group (WB) of 160,000 million dollars approved by the credit agency to help developing countries fight the COVID-19 pandemic between now and June next year. .
The funding will also provide “technical support so that developing countries can prepare for large-scale vaccine deployment, in coordination with international partners.”
According to the WB, the pharmaceutical and research industry must bear in mind that Citizens of developing countries also need access to safe and effective COVID-19 vaccines.
“We are expanding our fast-track approach to addressing the COVID emergency so that developing countries have fair and equitable access to vaccines,” WB President David Malpass said in the statement.
“Access to safe and effective vaccines and strong delivery systems is key to altering the course of the pandemic and helping countries suffering from catastrophic economic and fiscal shocks move towards recovery,” he added.
In addition to the purchase of vaccines against COVID-19, funding will also help developing countries access tests and treatments and expanding the immunization capacity of their health systems to manage them.
This includes supply chain management and logistics for vaccine storage management, trained health personnel to apply them, and large-scale communication and outreach campaigns to reach communities and households.
The agency indicated that countries will have different ways of acquiring and distributing vaccines against COVID-19 once they are approved, something for which they can count on your support.
The World Bank has extensive experience in supporting large-scale vaccination programs as well as public health policies to address infectious diseases such as HIV, tuberculosis, malaria, and neglected tropical diseases.
This financing, according to the World Bank, is part of emergency response programs to the pandemic from the agency that are already reaching 111 countries.
The WB’s $ 12 billion fund is based on the agency’s broader health program, focused on strengthening health systems and health service delivery.
The International Finance Corporation (IFC), the WB’s arm dedicated to the private sector, will also invest in vaccine manufacturing through its $ 4 billion Global Health Platform.
The goal is to encourage accelerated production of COVID-19 vaccines and therapies in both advanced and developing economies, and ensure emerging markets gain access to doses.